UK Patients Receive First CannEpil® Delivery through ‘I AM Billy Foundation’ and GMC Specialist Register
MGC Pharma’s pioneering cannabis-based treatment for refractory epilepsy now available to patients in the United Kingdom LONDON, May 31, 2023 /PRNewswire/ — MGC Pharmaceuticals Ltd. (LSE: MXC), (ASX: MXC), (OTC: MGCLF), a leading European pharmaceutical firm specializing in plant-derived medications, announced today that its ground-breaking Investigational Medicinal Product (IMP), CannEpil®, has been successfully imported and received … Read more